This requires Flash to play. Click here to download.

The information on this site is intended for health care professionals
in the United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
Zolinza® [vorinostat] capsules Reactivate Expression
Home About ZOLINZA Efficacy Safety profile Dosage Reimbursement Resource center CTCL overview Prescribing Information Patient Information
Patient Product Information

Resource center

Resources are available here to help support health care providers. Click on the links below for more information.

Medical Society Links
These medical societies may be able to provide additional information and support for you and your patients during their treatment with ZOLINZA.

Internet resources
These Web links share information about emerging oncology targets to further improve patient treatment.

ePrints
Visit this page to find downloadable ePrints.

CTCL resource center
Sign up to receive educational resources for your practice. Resources include disease-awareness brochures, treatment-related support materials, patient-reimbursement materials, downloads, e-mail updates, and more.


Home | Patient Information | Prescribing Information
ZOLINZA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

This site is intended only for health care professionals of the United States, its territories, and Puerto Rico.

20951007(6)-07/09-ZOL
For general information and other services for physicians
MERCK MEDICUSMERCK SOURCEMERCKServices
MerckMedicus, MerckSource, and MerckServices are trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.